MSD Assays for Commercial Application and Development

We offer the complete suite of MSD singleplexed and multiplex immunoassays to quantitate biomarkers to support your drug discovery, nonclinical, and clinical validation needs. With no lead times, Sword Bio has the expertise with MSD to support your assay development, validation, and sample testing for GLP, GCP and RUO projects.

The Sword Difference

We can analyze your nonclinical or clinical samples for specific biomarkers using the existing MSD singleplex or multiplex panels.
Alternatively, using the MSD platform and reagents, we can develop customized assays specific to your projects unique needs.

illustration of computer and desktop items
abstract science related illustration

How Our Team Can Help

Biomarker Analysis

  • Precise quantitation of disease biomarkers using MSD singleplexed or multiplexed biomarker panels (S-PLEX, V-PLEX, U-PLEX, R-PLEX, and T-PLEX)
  • Proprietary singleplexed or multiplexed immunoassay development
  • High performance (high sensitivity, accuracy, precision) immunoassay development
  • Fit-for-purpose method performance qualification
  • Intracellular signaling (phosphorylation) immunoassays
  • Competitive immunoassays
  • Protein-protein interaction assays
  • Biomarker analysis can be performed under Non-GLP or GLP

Top Benefits of MSD Assays:

Sword bio is capable of running all MSD singleplex and multiplex kits and has qualified the below:

  • High Sensitivity
  • Broad Dynamic Range
  • Robust & Rugged
  • High Throughput
  • Adaptability to Automation
  • Small Sample Volumes
  • Multiplexing

Below is an example of some of the qualified biomarkers we currently run, please reach out for a full list:

V-PLEX Human Biomarker 40-Plex Kit
IL-8IL-1αMDCFGF (basic)